Claim OwnershipUrology Times Podcasts
Subscribed: 26Played: 143
Subscribe
Description
Urology Times Podcasts is the official podcast platform for Urology Times®, including Speaking of Urology, MEDcast, and Pearls & Perspectives. Be sure to subscribe to stay up to date with the latest in expert clinical analysis, practice advice, and timely and informative insights from leaders in urology.
135 Episodes
Reverse
In this episode, guideline committee chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
Panelists examine disease heterogeneity in NMIBC and discuss a balanced treatment approach that prioritizes patient quality of life and surgery effectiveness.
Jack R. Andrews, MD; Eugene B. Cone MD; and Edwin Posadas, MD, FACP, discuss how early intervention with individualized treatment approaches based on disease volume, patient characteristics, and biomarkers significantly improves survival outcomes in metastatic hormone-sensitive prostate cancer.
Timecodes
1:35 Individualized Care for PC
9:24 Frailty & Comorbidities in PC
12:27 Molecular Testing in PC
18:10 Sequencing in PC
22:00 Doublets/Triplets in mHSPC
30:00 Subgroups in mHSPC
39:00 ARASENS Subgroup Analysis
43:55 Future of mHSPC Care
Wayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distinguishing from benign prostatic hyperplasia in men, impacts quality of life in older adults, benefits from early primary care intervention, and necessitates improved patient advocacy and educational initiatives for optimal management outcomes.
Jack Andrews MD; Eugene Cone, MD; and Arash Rezazadeh, MD, discuss how metastatic hormone-sensitive prostate cancer presents clinically, explore current treatment standards including combination therapies, evaluate emerging data from the ARANOTE trial on darolutamide efficacy, consider quality of life factors in treatment selection, and examine how novel therapeutic approaches may reshape future care pathways.
Timecodes
1:54 mHSPC and Imaging
4:57 Current SOC in mHSPC
10:15 Choosing Therapy in mHSPC
18:51 ARANOTE Trial in mHSPC
21:15 Experience With ARI
27:08 Emerging mHSPC Treatments
32:51 ARANOTE Subgroup Analysis
35:31 Future Outlook for mHSPC
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
In this episode of Speaking of Urology®, former Major League Baseball (MLB) player, Dave Winfield, shares lessons he’s learned throughout his professional baseball career and his work in philanthropy. Winfield delivered a keynote presentation at this year’s LUGPA Annual Meeting titled, “Leadership Lessons Learned from Baseball, Business and Philanthropy.”
In this episode of Speaking of Urology®, Juan J. Andino, MD, MBA, speaks with Robert E. Brannigan, MD on the recent amendment to the American Urological Association (AUA) guideline on male infertility. This discussion originally took place during a live X (formerly Twitter) Spaces event held by Urology Times®.
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen. Winter is a urologist and sexual medicine expert in Los Angeles, California.
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy for urology and recap the American Urological Association’s (AUA) recent Annual Urology Advocacy Summit, which took place from February 26-28 in Washington DC.
In this interview, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
In this episode of Speaking of Urology®, David M. Albala, MD, and Sanoj Punnen, MD, discuss precision medicine and the use of biomarker tests in prostate cancer screening and detection. Albala is the chief of urology at Crouse Hospital in Syracuse, New York, and Punnen is an associate professor of urologic oncology and an associate professor and vice chair of research at the Desai Sethi Urology Institute at the University of Miami in Florida.
This discussion originally took place during a live X (formerly Twitter) Spaces event held by Urology Times. In this exclusive interview, Albala and Punnen discussed the significance of advances such as liquid biopsies in prostate cancer, reviewed the current liquid biopsy tests available, and shared their own clinical experiences with the tests in their practice. They also highlighted data on the ExoDx prostate test from studies of clinical utility and validation studies.1,2,3
Albala and Punnen ended their discussion by highlighting current ed
In this interview, Janelle Bunce, PA-C highlights the role that advanced practice providers (APPs) can play in filling the gaps created by the growing workforce shortages in urology. Bunce is a physician assistant at Advanced Urology Institute in Naples, Florida.
In this episode, David M. Schuster, MD, FACR, highlights the recent FDA approval of flotufolastat F 18 (POSLUMA), a PSMA-PET imaging agent in prostate cancer. Schuster is a professor of radiology and imaging sciences and the director of the division of nuclear medicine and molecular imaging at Emory University School of Medicine in Atlanta, Georgia.
In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in honor of Bladder Cancer Awareness Month this May.
In this episode of Speaking of Urology®, Gopal H. Badlani, MD, and Steven A. Kaplan, MD, discuss some of the notable abstracts in benign urology that were presented at the 2023 American Urological Association Annual Meeting, which was held April 28-May 1 in Chicago, Illinois. Badlani is a Urology Times coeditor in chief and professor and vice chair of urology at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, and Dr. Kaplan is a professor of Urology and a director of the men’s wellness program at the Icahn School of Medicine at Mount Sinai in New York.
In this episode, Steven Gange, MD, FACS, discusses notable data on the UroLift System for the treatment of patients with benign prostatic hyperplasia (BPH), which were presented at the 2023 American Urological Association Annual Meeting in Chicago, Illinois. Gange is a urologist at Summit Urology Group in Salt Lake City, Utah as well as an Associate Medical Director for Teleflex.
In this episode of Speaking of Urology®, Adam B. Weiner, MD, and Ruchika Talwar, MD, discuss some of the notable urologic oncology abstracts that were presented at the 2023 American Urological Association Conference, which was held April 28-May 1 in Chicago, Illinois. Weiner is a urologic oncology fellow at the University of California, Los Angeles, and Talwar is a urologic oncology fellow at Vanderbilt University in Nashville, Tennessee.
This recap was originally presented by Dr. Weiner and Dr. Talwar during a live Twitter Spaces event held by Urology Times.
Comments
Download from Google Play
Download from App Store
United States